IL214285A - Pharmaceutical composition for use in treating inflammatory, autoimmune and cardiovascular diseases comprising an anti eotaxin-2 antibody - Google Patents

Pharmaceutical composition for use in treating inflammatory, autoimmune and cardiovascular diseases comprising an anti eotaxin-2 antibody

Info

Publication number
IL214285A
IL214285A IL214285A IL21428511A IL214285A IL 214285 A IL214285 A IL 214285A IL 214285 A IL214285 A IL 214285A IL 21428511 A IL21428511 A IL 21428511A IL 214285 A IL214285 A IL 214285A
Authority
IL
Israel
Prior art keywords
autoimmune
antibody
pharmaceutical composition
cardiovascular diseases
treating inflammatory
Prior art date
Application number
IL214285A
Other languages
Hebrew (he)
Other versions
IL214285A0 (en
Original Assignee
Medical Res Infrastructure & Health Services Fund
Medical Res Fund At The Tel Aviv Sourasky Medical Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2010/000073 external-priority patent/WO2010086854A1/en
Application filed by Medical Res Infrastructure & Health Services Fund, Medical Res Fund At The Tel Aviv Sourasky Medical Ct filed Critical Medical Res Infrastructure & Health Services Fund
Priority to IL214285A priority Critical patent/IL214285A/en
Publication of IL214285A0 publication Critical patent/IL214285A0/en
Publication of IL214285A publication Critical patent/IL214285A/en

Links

IL214285A 2009-01-28 2011-07-26 Pharmaceutical composition for use in treating inflammatory, autoimmune and cardiovascular diseases comprising an anti eotaxin-2 antibody IL214285A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL214285A IL214285A (en) 2009-01-28 2011-07-26 Pharmaceutical composition for use in treating inflammatory, autoimmune and cardiovascular diseases comprising an anti eotaxin-2 antibody

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20208909P 2009-01-28 2009-01-28
US24453009P 2009-09-22 2009-09-22
PCT/IL2010/000073 WO2010086854A1 (en) 2009-01-28 2010-01-28 Eotaxin-2 (ccl24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders
IL214285A IL214285A (en) 2009-01-28 2011-07-26 Pharmaceutical composition for use in treating inflammatory, autoimmune and cardiovascular diseases comprising an anti eotaxin-2 antibody

Publications (2)

Publication Number Publication Date
IL214285A0 IL214285A0 (en) 2011-09-27
IL214285A true IL214285A (en) 2015-09-24

Family

ID=45773707

Family Applications (1)

Application Number Title Priority Date Filing Date
IL214285A IL214285A (en) 2009-01-28 2011-07-26 Pharmaceutical composition for use in treating inflammatory, autoimmune and cardiovascular diseases comprising an anti eotaxin-2 antibody

Country Status (1)

Country Link
IL (1) IL214285A (en)

Also Published As

Publication number Publication date
IL214285A0 (en) 2011-09-27

Similar Documents

Publication Publication Date Title
IL260285B (en) Anti-gcc antibody molecules and related compositions and methods
PT2226173E (en) Apparatus for injection moulding, in particular cascade injection moulding and use of the apparatus
PL3118223T3 (en) Anti mif antibodies for use in treating inflammatory diseases
SG10201403758SA (en) Methods and compositions for use in cellular therapies
HK1210157A1 (en) Anti inflammatory 2-oxothiazoles and 2-oxooxazoles 2- 2-
HRP20181973T1 (en) Improved anti human fraktalkine antibodies and uses thereof
EP2279003A4 (en) An anti-cd137 antibody as an agent in the treatment of inflammatory conditions
IL212066A (en) Anti cxcr4 antibodies, compositions comprising them, processes for their production and selection and use thereof
EP2316935A4 (en) Aptamer against il-17 and use thereof
IL211034A0 (en) Treatment of autoimmune and inflammatory disease
IL236237A (en) Tmem154 antibodies and fragments and uses thereof
HK1178917A1 (en) Anti-bv8 antibodies and uses thereof bv8
EP2484697A4 (en) Anti-podoplanin antibody, and pharmaceutical composition containing anti-podoplanin antibody
EP2410337A4 (en) Method for measuring beta -glucan, and beta-glucan-binding protein for use in the method
EP2427767A4 (en) Means and methods for recognizing the development of cardiovascular disease in an individual
EP2388320A4 (en) Anti-hs6st2 antibodies and use thereof
GB0903151D0 (en) Antibody uses and methods
HK1164193A1 (en) Anti-mst1r antibodies and uses thereof mst1r
EP2484693A4 (en) Human serum amyloid-a3 antibody and use thereof
IL214285A (en) Pharmaceutical composition for use in treating inflammatory, autoimmune and cardiovascular diseases comprising an anti eotaxin-2 antibody
GB0812277D0 (en) Antibody and uses thereof
EP2276468A4 (en) Demulsifiers and methods for use in pharmaceutical applications
GB0906115D0 (en) Antibody and uses thereof
IL216121A0 (en) Means and methods for recognizing the development of cardiovascular disease in an individual
GB0922414D0 (en) Compression moulding in metal

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed